Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle

World Journal of Urology

Volumn 15, Issue 1, 1997, Pages 32-35

  Taher, A ^a   Meyer, M ^b   Stief, C G ^a   Jonas, U ^a   Forssmann, W G ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b IPF PHARMACEUTICALS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 PYRROLIDONE DERIVATIVE; CYCLIC AMP; CYCLIC GMP; ISOENZYME; PAPAVERINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PURINE DERIVATIVE; QUAZINONE; QUINAZOLINE DERIVATIVE; ROLIPRAM; ZAPRINAST;

ANIMAL; ARTICLE; DRUG EFFECT; ENZYMOLOGY; HUMAN; IN VITRO STUDY; MALE; METABOLISM; PENIS; PENIS ERECTION; SMOOTH MUSCLE;

ANIMALS; CYCLIC AMP; CYCLIC GMP; HUMANS; ISOENZYMES; MALE; MUSCLE, SMOOTH; PAPAVERINE; PENILE ERECTION; PENIS; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PURINONES; PYRROLIDINONES; QUINAZOLINES; ROLIPRAM;

EID: 0030637901     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01275154     Document Type: Article

References (15)

1. Adaikan PG (1992) Comment on the mechanism for the regulation of penile smooth muscle contractility. In: Lue TF (ed) World book of impotence. Stockton Press, Houndmills, pp 52-56
2. Ahn HS, Crim W, Romano M, Sybertz E, Pitts B (1989) Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta. Biochem Pharmacol 38: 3331-3339
3. Beavo JA (1988) Multiple isoenzymes of cyclic nucleotide phosphodiesterase. Adv Second Messengers Phosphoprotein Res 22: 1-38
4. Beavo JA, Reifsnyder DH (1990) Primary sequence of cyclic nucleotide phosphodiesterase isoenzymes and the design of selective inhibitors. TIPS 11: 150-155
5. Christ GJ, Valvic M, Maayani S, Melman A (1989) Kinetic studies of contraction in human erectile tissue (HET) and rabbit aortic rings in vitro: modulation by papaverine and the dihydropyridine analog nifedipine. Int J Impotence Res 1: 1-10
6. De Tejada IS (1992) Mechanism for the regulation of penile smooth muscle contractility. In: Lue TF (ed) World book of impotence. Stockton Press, Houndmills, pp 39-48
7. Ferrari M (1973) Effects of papaverine on smooth muscle and their mechanisms. Pharmacol Res Commun 6: 97-114
8. Leroy MJ, Cedrin I, Giovagrandi Y, Ferre F (1989) Correlation between selective inhibition of the cyclic nucleotide phosphodiesterases and the contractile activity in human pregnant myometrium near term. Biochem Pharmacol 1: 9-15
9. Nicholson CD, Challiss J, Shahid M (1991) Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. TIPS 12: 19-27
10. Poch G, Kukovetz WR (1971) Papaverine-induced inhibition of phosphodiesterase activity in various mammalian tissue. Life Sci 10: 133-144
11. Rall TW (1982) Fomation and degradation of cyclic nucleotides: an overview. In: Nathanson JA, Kebabian CN (eds) Handbook of pharmacology. Willey, Sussex, p 3
12. Reeves ML, Leigh BK, England PJ (1987) The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors. Biochem J 241: 535-547
13. Silver PJ, Hamel LT, Perrone MH, Bentley RG, Bushover CR, Evans DB (1988) Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isoenzymes isolated from cardiac muscle, arterial and airway smooth muscle. Eur J Pharmacol 150: 85-94
14. Thompson WJ, Brooker G, Appleman MM (1971) Assay of cyclic nucleotide phosphodiesterases with radioactive substrates. Biochemistry 10: 311
15. Torphy TJ, Cieslinski LB (1989) Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isoenzymes in canine tracheal smooth muscle. Mol Pharmacol 37: 206-214